{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:24:58Z","timestamp":1793849098392,"version":"4.6.1"},"reference-count":23,"publisher":"Maad Rayan Publishing Company","content-domain":{"domain":["ijhpm.com"],"crossmark-restriction":false},"short-container-title":["Int J Health Policy Manag"],"published-print":{"date-parts":[[2024,5,18]]},"abstract":"<jats:p>This paper discusses the potential of an international agreement to ensure equitable vaccine distribution, addressing the failures witnessed during the COVID-19 pandemic. COVAX was unable to prevent vaccine monopolization and unequal distribution, which led to significant disparities in vaccination rates and avoidable deaths. Any future agreement on equitable vaccine distribution must address ethical and practical issues to ensure global health equity and access. The proposed agreement should recognize healthcare as a human right and consider vaccines beyond mere commodities, emphasizing the social responsibility of pharmaceutical companies to prioritize affordability, availability, and accessibility, particularly for low-income countries (LICs). Voluntary licensing agreements are suggested as a means to enhance access to essential medicines. The paper also outlines the necessity of international cooperation, with robust compliance mechanisms, to effectively enforce such an agreement and mitigate future health crises.<\/jats:p>","DOI":"10.34172\/ijhpm.2024.8516","type":"journal-article","created":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T09:03:46Z","timestamp":1720688626000},"page":"8516","update-policy":"https:\/\/doi.org\/10.34172\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Ethical and Practical Considerations for an Agreement to Ensure Equitable Vaccine Access Comment on \"More Pain, More Gain! The Delivery of COVID-19 Vaccines and the Pharmaceutical Industry\u2019s Role in Widening the Access Gap\""],"prefix":"10.34172","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7203-3974","authenticated-orcid":true,"given":"Gustavo","family":"Ortiz-Mill\u00e1n","sequence":"first","affiliation":[{"name":"Instituto de Investigaciones Filos\u00f3ficas, Universidad Nacional Aut\u00f3noma de M\u00e9xico, Ciudad Universitaria, Mexico City, Mexico."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"20123","published-online":{"date-parts":[[2024,5,18]]},"reference":[{"key":"R1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n281"},{"key":"R2","first-page":"96","article-title":"The tragedy of vaccine nationalism: only cooperation can end the pandemic","volume":"99","author":"Bollyky TJ","year":"2020","journal-title":"Foreign Aff"},{"key":"R3","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02064-y"},{"key":"R4","unstructured":"Mathieu E, Ritchie H, Rod\u00e9s-Guirao L, et al. Coronavirus Pandemic (COVID-19). https:\/\/ourworldindata.org\/coronavirus. Accessed April 23, 2024."},{"key":"R5","doi-asserted-by":"publisher","DOI":"10.34172\/ijhpm.2022.6942"},{"key":"R6","unstructured":"World Health Organization (WHO). Revised Draft of the Negotiating Text of the WHO Pandemic Agreement. https:\/\/apps.who.int\/gb\/inb\/pdf_files\/inb9\/A_inb9_3-en.pdf. Accessed April 19, 2024."},{"key":"R7","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(21)01378-7"},{"key":"R8","unstructured":"M\u00e9decins Sans Fronti\u00e8res Access Campaign. Voluntary Licenses and Access to Medicines: M\u00e9decins Sans Fronti\u00e8res Technical Briefing Document. 2020. https:\/\/msfaccess.org\/sites\/default\/files\/2020-10\/IP_VoluntaryLicenses_full-brief_Oct2020_ENG.pdf. Accessed April 22, 2024."},{"key":"R9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2023-012964"},{"key":"R10","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe2803"},{"key":"R11","doi-asserted-by":"crossref","unstructured":"Ortiz-Mill\u00e1n G. How populism affects bioethics. Camb Q Healthc Ethics. 2024:1-15. doi:10.1017\/s0963180124000161.","DOI":"10.1017\/S0963180124000161"},{"key":"R12","doi-asserted-by":"publisher","DOI":"10.1177\/00076503231158600"},{"key":"R13","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(23)01527-1"},{"key":"R14","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(16)31601-4"},{"key":"R15","doi-asserted-by":"publisher","DOI":"10.2471\/blt.08.053686"},{"key":"R16","unstructured":"Hey E. The Principle of Common but Differentiated Responsibilities. UN Legal. https:\/\/legal.un.org\/avl\/pdf\/ls\/Hey_outline%20EL.pdf. Accessed April 19, 2024."},{"key":"R17","doi-asserted-by":"publisher","DOI":"10.1057\/s42214-021-00124-7"},{"key":"R18","unstructured":"Shinh R. Pandemic Bonds: What Are They and How Do They Work? Actuaries in Government. March 2, 2021. https:\/\/actuaries.blog.gov.uk\/2021\/03\/02\/pandemic-bonds-what-are-they-and-how-do-they-work\/. Accessed April 22, 2024."},{"key":"R19","unstructured":"Humphrey C, Prizzon A. Scaling Up Multilateral Bank Finance for the COVID-19 Recovery. ODI; 2020. https:\/\/odi.org\/en\/insights\/scaling-up-multilateral-bank-finance-for-the-covid-19-recovery\/. Accessed April 19, 2024."},{"key":"R20","unstructured":"Gavi, The Vaccine Alliance. Analysis Paper\u2013A Preliminary Assessment of COVAX\u2019s Impact in Lower-Income Countries. Gavi, The Vaccine Alliance; 2023. https:\/\/www.gavi.org\/sites\/default\/files\/white-paper\/2023\/COVAX_Analysis-Paper.pdf."},{"key":"R21","doi-asserted-by":"crossref","unstructured":"A patent waiver on COVID vaccines is right and fair. Nature 2021; 593(7860):478.\u2005doi:10.1038\/d41586-021-01242-1.","DOI":"10.1038\/d41586-021-01242-1"},{"key":"R22","unstructured":"Rouw A, Wexler A, Kates J, Toole K, Britto A, Katz R. Assessing the Role of Treaties, Conventions, Institutions, and Other International Agreements in the Global COVID-19 Response: Implications for the Future. Global Health Policy. 2023. https:\/\/www.kff.org\/global-health-policy\/issue-brief\/assessing-the-role-of-treaties-conventions-institutions-and-other-international-agreements-in-the-global-covid-19-response-implications-for-the-future\/. Accessed April 19, 2024."},{"key":"R23","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2122854119"}],"container-title":["International Journal of Health Policy and Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ijhpm.com\/article_4597_64561f2343679f76d9e64c50cd709d5b.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ijhpm.com\/article_4597_64561f2343679f76d9e64c50cd709d5b.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T09:03:54Z","timestamp":1720688634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ijhpm.com\/article_4597.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,18]]},"references-count":23,"URL":"https:\/\/doi.org\/10.34172\/ijhpm.2024.8516","relation":{},"ISSN":["2322-5939"],"issn-type":[{"value":"2322-5939","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,18]]},"assertion":[{"value":"Kerman University of Medical Sciences","name":"journal_owner","label":"Journal Owner"},{"value":"Kerman University of Medical Sciences","name":"journal_publisher","label":"Journal Publisher"},{"value":"2024-04-01","order":1,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}